By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Acceleron Pharma 

128 Sidney Street

Cambridge  Massachusetts    U.S.A.
Phone: 617-649-9200 Fax: 617-649-9988


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Alkermes 





Company News
Acceleron Pharma To Present At Upcoming Investor Conferences In May 4/23/2015 10:22:40 AM
Acceleron Pharma Announces Oral Presentations Of Luspatercept And Sotatercept Data At The 13th International Symposium On Myelodysplastic Syndromes 4/7/2015 10:42:23 AM
Acceleron Pharma Appoints Dr. Francois Nader As Chairman Of Its Board Of Directors 4/6/2015 10:24:59 AM
Acceleron Pharma Announces Executive Appointments And Promotions 3/6/2015 7:51:41 AM
Acceleron Pharma Reports Fourth Quarter And Year Ended 2014 Financial And Operational Results 3/2/2015 10:31:39 AM
Acceleron Pharma Presents Encouraging Response Rates And Progression-Free Survival Data In Patients With Advanced Renal Cell Carcinoma At The American Society Of Clinical Oncology (ASCO) 2015 Genitourinary Cancers Symposium 3/2/2015 9:08:22 AM
Acceleron Pharma To Present At Upcoming Investor Conferences In March 2/26/2015 11:42:11 AM
Acceleron Pharma To Host Fourth Quarter And Year Ended 2014 Financial Results Conference Call And Webcast On March 2, 2015 2/24/2015 10:57:53 AM
Acceleron Pharma TO Present New Dalantercept Clinical Data At The American Society of Clinical Oncology 2015 Genitourinary Cancers Symposium 2/19/2015 12:20:35 PM
Acceleron Pharma To Present At Upcoming Investor Conferences In February 1/28/2015 11:14:18 AM
12345678910...
//-->